Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis

Journal of Neuropathology and Experimental Neurology

Volumn 60, Issue 12, 2001, Pages 1190-1197

  Atzori, Cristiana ^a   Ghetti, Bernardino ^b   Piva, Roberto ^a   Srinivasan, Anu N ^c   Zolo, Paolo ^d   Delisle, Marie Bernadette ^e   Mirra, Suzanne S ^f   Migheli, Antonio ^a,g  

^a Laboratory of Neuropathology   (Italy)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PFIZER INC   (United States)

^d IRCCS POLICLINICO SAN DONATO   (Italy)

^e TOULOUSE UNIVERSITY HOSPITAL   (France)

^f SUNY DOWNSTATE MEDICAL CENTER   (United States)

^g UNIVERSITY OF TURIN   (Italy)

Author keywords

Apoptosis; JNK; MAP kinase; p38; Phosphorylation; Tau; Tauopathy

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TAU PROTEIN;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CHROMOSOME 17; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; DNA DEGRADATION; ENZYME ACTIVATION; ENZYME LOCALIZATION; FRONTOTEMPORAL DEMENTIA; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NERVE CELL; OXIDATIVE STRESS; PARKINSONISM; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN PHOSPHORYLATION;

EID: 0035208849     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/60.12.1190     Document Type: Article

References (41)

1. Aberrant protein deposition and neuroloical diseases
2. Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases
3. Tau protein pathology in neurodegenerative diseases
4. Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy
5. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
6. Frontotemporal dementia and Parkinsonism linked to chromosome 17: A new group of tauopathies
7. Gerstmann-SträusslerScheinker disease and the Indiana kindred
8. The distribution of tau in the mammalian central nervous system
9. Light and electron microscope localization of the microtubule-associated tau protein in rat brain
10. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease
11. Tau in Alzheimer's disease
12. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease
13. Regulated phosphorylation and dephosphorylation of tau protein: Effects on microtubule interaction, intracellular trafficking and neurodegeneration
14. Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments
15. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
16. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases
17. p38 kinase is activated in the Alzheimer's disease brain
18. Stressactivated protein kinase/c-jun N-terminal kinase phosphorylates tau protein
19. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: Differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and p38, and glycogen synthase kinase-3beta
20. Mammalian MAP kinase signalling cascades
21. JNK and p38 stress kinases: Degenerative effectors of signal-transduction-cascades in the nervous system
22. Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease
23. Induction of apoptosis signal regulating kinase 1 (ASK1) after spinal cord injury in rats: Possible involvement of ASK1-JNK and -p38 pathways in neuronal apoptosis
24. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
25. JNK activation is associated with intracellular beta-amyloid accumulation
26. Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease
27. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation
28. Localization of the mitogen activated protein kinase ERK2 in Alzheimer's disease neurofibrillary tangles and senile plaque neurites
29. Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration
30. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease
31. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
32. Tau pathology in a family with dementia an a P301L mutation in tau
33. A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy
34. Tau gene mutation G389R causes a tauopathy with abundant Pick body-like inclusions and axonal deposits
35. A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks
36. Diverse cell death pathways result from a single missense mutation in weaver mouse
37. Evidence for neuronal apoptosis in pontosubicular neuron necrosis
38. DNA damage distribution in the human brain as shown by in situ end labeling: Area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology
39. Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments
40. c-Jun, JNK/SAPK kinases and transcription factor NF-KB are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis
41. In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease